Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$984M |
| 2 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$406M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$363M |
| 4 |
Comcast
CMCSA
|
+$305M |
| 5 |
DuPont de Nemours
DD
|
+$229M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.98B |
| 2 |
Linde
LIN
|
+$1.14B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$976M |
| 4 |
AGN
Allergan plc
AGN
|
+$735M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$469M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.7% |
| 2 | Financials | 4.92% |
| 3 | Consumer Discretionary | 4.46% |
| 4 | Healthcare | 4.33% |
| 5 | Communication Services | 4.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CGC
1951
Canopy Growth
CGC
$402M
| $2.35M | ﹤0.01% |
14,546
-32,981
| -69% | -$5.34M |
|
1952
Darling Ingredients
DAR
$9.99B
| $2.35M | ﹤0.01% |
95,385
+40,473
| +74% | +$881K |
|
1953
PUT
Genworth Financial
GNW
$3.75B
| $2.35M | ﹤0.01% |
1,015,100
-46,000
| -4% | -$145K |
|
1954
Vanguard Industrials ETF
VIS
$8.44B
| $2.35M | ﹤0.01% |
18,050
| – | – |
|
1955
Columbia Sportswear
COLM
$2.92B
| $2.34M | ﹤0.01% |
29,063
-30,716
| -51% | -$2.24M |
|
|
BNY
1956
PUT
Bank of New York Mellon
BNY
$108B
| $2.34M | ﹤0.01% |
60,500
-47,500
| -44% | -$1.74M |
|
1957
Hubbell
HUBB
$26.7B
| $2.34M | ﹤0.01% |
18,625
+1,665
| +10% | +$203K |
|
|
MEET
1958
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $2.34M | ﹤0.01% |
374,416
+27,564
| +8% | +$170K |
|
1959
Rogers Corp
ROG
$2.29B
| $2.33M | ﹤0.01% |
18,728
+2,223
| +13% | +$238K |
|
|
MNR
1960
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.33M | ﹤0.01% |
160,945
+98,471
| +158% | +$1.28M |
|
|
EPAY
1961
DELISTED
Bottomline Technologies Inc
EPAY
| $2.33M | ﹤0.01% |
45,912
-120
| -0.3% | -$5.36K |
|
1962
ePlus
PLUS
$2.35B
| $2.33M | ﹤0.01% |
65,972
+4,370
| +7% | +$149K |
|
1963
Gibraltar Industries
ROCK
$1.45B
| $2.33M | ﹤0.01% |
48,538
+16,046
| +49% | +$713K |
|
|
TCO
1964
PUT
DELISTED
Taubman Centers Inc.
TCO
| $2.33M | ﹤0.01% |
+61,700
| New | +$2.52M |
|
|
ITCI
1965
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.33M | ﹤0.01% |
90,722
+68,101
| +301% | +$1.38M |
|
1966
BWX Technologies
BWXT
$15.5B
| $2.33M | ﹤0.01% |
41,101
-175,540
| -81% | -$9.81M |
|
1967
First Financial Bankshares
FFIN
$4.93B
| $2.33M | ﹤0.01% |
80,562
+37,454
| +87% | +$1.05M |
|
1968
MACOM Technology Solutions
MTSI
$22.7B
| $2.32M | ﹤0.01% |
67,595
+10,674
| +19% | +$312K |
|
1969
Innospec
IOSP
$2.29B
| $2.32M | ﹤0.01% |
30,035
+5,928
| +25% | +$433K |
|
1970
Boston Beer
SAM
$1.86B
| $2.32M | ﹤0.01% |
4,322
-6,770
| -61% | -$3.28M |
|
1971
CareTrust REIT
CTRE
$9.55B
| $2.32M | ﹤0.01% |
135,195
+45,768
| +51% | +$799K |
|
1972
Assured Guaranty
AGO
$3.36B
| $2.32M | ﹤0.01% |
94,928
+15,892
| +20% | +$433K |
|
1973
HEICO Corp Class A
HEI.A
$37B
| $2.32M | ﹤0.01% |
28,503
-53,077
| -65% | -$4.12M |
|
1974
PUT
PG&E
PCG
$37.5B
| $2.3M | ﹤0.01% |
259,500
+239,500
| +1,198% | +$2.61M |
|
1975
CALL
Factset
FDS
$10.1B
| $2.3M | ﹤0.01% |
7,000
-1,800
| -20% | -$520K |
|
Similar funds
Barclays's Q2 2020 Portfolio in Review
As of Q2 2020, Barclays held 6,627 positions worth $129B, up 2.3% from $127B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $22.7B in Q2 2020, closing 960 positions and reducing 2,655 holdings. Its most notable exit was Allergan plc, an estimated $735M position sold in full.
By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 8.3% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares MSCI ACWI ex US ETF worth $123M.
- Barclays's largest Q2 2020 buy was iShares MSCI ACWI ex US ETF: 2,853,067 shares worth $123M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, an estimated $984M increase.
- Barclays's biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.98B.
- Barclays fully exited Allergan plc in Q2 2020, selling an estimated $735M.
- Barclays's ten largest holdings make up 34% of its $129B portfolio in Q2 2020.
- Barclays opened 468 new positions and closed 960 in Q2 2020.
- Barclays's portfolio value rose 2.3% quarter-over-quarter to $129B.
Based on Barclays's 13F filing for Q2 2020, filed 12 Aug 2020.